Erectile dysfunction, obesity, insulin resistance, and their relationship with testosterone levels in eugonadal patients in an andrology clinic setting

Journal of Andrology

Volumn 31, Issue 3, 2010, Pages 263-270

  Knoblovits, Pablo ^a   Costanzo, Pablo R ^a   Rey Valzacchi, Gastón J ^a   Gueglio, Guillermo ^a   Layus, Alberto O ^a   Kozak, Andrea E ^a   Balzaretti, Marta I ^a   Litwak, León E ^a  

^a HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

Author keywords

Male sexual function; Obesity; Waist circumference

Indexed keywords

TESTOSTERONE;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; ERECTILE DYSFUNCTION; GONAD; HUMAN; INSULIN RESISTANCE; INTERNATIONAL INDEX OF ERECTILE FUNCTION; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; WAIST CIRCUMFERENCE; COMPLICATION; HOMEOSTASIS; METABOLIC SYNDROME X; PHYSIOLOGY;

ADULT; AGED; BODY MASS INDEX; ERECTILE DYSFUNCTION; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; OBESITY; TESTOSTERONE; WAIST CIRCUMFERENCE;

EID: 77954929991     PISSN: 01963635     EISSN: 19394640     Source Type: Journal    
DOI: 10.2164/jandrol.109.007757     Document Type: Article

References (37)

1. Abate N, Haffner SM, Garg A, Peshock RM, Grundy SM. Sex steroid hormones, upper body obesity, and insulin resistance. J Clin Endocrinol Metab. 2002;87(10):4522-4527.
2. Bal K, Oder M, Sahin AS, Karathaş CT, Demir O, Can E, Gümüş BH, Ozer K, Sahin O, Esen AA. Prevalence of metabolic syndrome and its association with erectile dysfunction among urologie patients: metabolic backgrounds of erectile dysfunction. Urology. 2007;69(2):356-360.
3. Bansal TC, Guay AT, Jacobson J, Woods BO, Nesto RW. Incidence of metabolic syndrome and insulin resistance in a population with organic erectile dysfunction. J Sex Med. 2005;2(1):96-103.
4. Barouch LA, Harrison RW, Skaf MW, Rosas GO, Cappola TP, Kobeissi ZA, Hobai IA, Lemmon CA, Burnett AL, O'Rourke B, Rodriguez ER, Huang PL, Lima JA, Berkowitz DE, Hare JM. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature. 2002;416(6878):337-339.
5. Boyanov MA, Boneva Z, Christov VG. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Aging Male. 2003;6(1):1-7.
6. Buvat J, Bou Jaoudé G. Significance of hypogonadism in erectile dysfunction. World J Urol. 2006;24(6):657-667.
7. Cersosimo E, De Fronzo R. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab Res Rev. 2006;22(6):423-436.
8. Corona G, Mannucci E, Petrone L, Schulman C, Balcrcia G, Fisher AD, Chiarini V, Forti G, Maggi M. A comparison of NCEP-ATPIII and IDF metabolic syndrome definitions with relation to metabolic syndrome-associated sexual dysfunction. J Sex Med. 2007;4(3):789-796.
9. Costanzo P, Knoblovits P, Rey Valzacchi G, Gueglio G, Layus O, Litwak L. Erectile dysfunction is associated with a high prevalence of obesity and metabolic syndrome. Rev Argent Endocrinol Metab. 2008;45(3):142-148.
10. Couillard C, Gagnon J, Bergeron J, Leon AS, Rao DC, Skinner JS, Wilmore JH, Després JP, Bouchard C. Contribution of body fatness and adipose tissue distribution to the age variation in plasma steroid hormone concentrations in men: the HERITAGE Family Study. J Clin Endocrinol Metab. 2000;85(3):1026-1031.
11. Demir T. Prevalence of erectile dysfunction in patients with metabolic syndrome. Int J Urol. 2006;13(4):385-388.
12. Esposito K, Giugliano F, Di Palo C, Giugliano G, Marfella R, D'Andrea F, D'Armiento M, Giugliano D. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA. 2004;291(24):2978-2984.
13. Feldman HA, Goldstein L, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151(1):54-61.
14. Fung MM, Bettencourt R, Barrett-Connor E. Heart disease risk factors predict erectile dysfunction 25 years later: the Rancho Bernardo Study. J Am Coll Cardiol. 2004;43(8):1405-1411.
15. Herbert V, Lau KS, Gottlieb CW, Bleicher SJ. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab. 1965;25(10): 1375-1384.
16. Holmäng A, Björntorp P. The effects of testosterone on insulin sensitivity in male rats. Acta Physiol Scand. 1992;146(4):505-510.
17. Jeremy JY, Angelini GD, Khan M, Mikhailidis DP, Morgan RJ, Thompson CS, Bruckdorfer KR, Naseem KM. Platelets, oxidant stress and erectile dysfunction: an hypothesis. Cardiovasc Res. 2000;46(1):50-54.
18. Jones RW, Rees RW, Minhas S, Ralph D, Persad RA, Jeremy JY. Oxygen free radicals and the penis. Expert Opin Pharmacother. 2003;3(7):889-897.
19. Kapoor D, Goodwin E, Channer KS, Jones TH. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol. 2006;154(6):899-906.
20. Kim YW, Park SY, Kim JY, Huh JY, Jeon WS, Yoon CJ, Yun SS, Moon KH. Metformin restores the penile expression of nitric oxide synthase in high-fat-fed obese rats. J Androl. 2007;28(4): 555-560.
21. Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ, McKinlay JB. Low sex hormone-binding globulin, total testoster-one, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab. 2006;91(3): 843-850.
22. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999;281(6):537-544. (Pubitemid 29081307)
23. Makhsida N, Shah J, Yan G, Fisch H, Shabsigh R. Hypogonadism and metabolic syndrome: implications for testosterone therapy. J Urol. 2005;174(3):827-834. (Pubitemid 41140604)
24. Mårin P. Testosterone and regional fat distribution. Obes Res. 1995;3(suppl 4):609s-612s.
25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-419.
26. McFarlane SI, Banerji M, Sowers JR. Insulin resistance and cardiovascular disease. J Clin Endocrinol Metab. 2001;86(7): 713-718.
27. Mikhail N. Does testosterone have a role in erectile function? Am J Med. 2006; 119(5):373-382.
28. Muller M, Grobbee DE, den Tonkelaar I, Lamberts SW, van der Schouw YT. Endogenous sex hormones and the metabolic syndrome in aging men. J Clin Endocrinol Metab. 2005;90(5): 2618-2623. (Pubitemid 40686299)
29. Pitteloud N, Hardin M, Dwyer AA, Valassi E, Yialamas M, Elahi D, Hayes FJ. Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men. J Clin Endocrinol Metab. 2005;90(5):2636-2641.
30. Rosen RC, Capelleri JC, Smith MD, Lipsky J, Peña BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11(6):319-326.
31. Saad F, Grahl AS, Aversa A, Yassin AA, Kadioglu A, Moncada I, Eardley I. Effects of testosterone on erectile function: implications for the therapy of erectile dysfunction. BJU Int. 2007;99(5): 988-992.
32. Sullivan ME, Thompson CS, Dashwood MR, Khan MA, Jeremy JY, Morgan RJ, Mikhailidis DP. Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease? Cardiovasc Res. 1999;43(3):658-665.
33. Traish AM, Guay A, Feeley R, Saad F. The dark side of testosterone deficiency, I: metabolic syndrome and erectile dysfunction. J Androl. 2009;30(1):10-22.
34. Trussell JC, Legro RS. Erectile dysfunction: does insulin resistance play a part? Fertil Steril. 2007;88(4):771-777.
35. Tsai EC, Matsumoto AM, Fujimoto WY, Boyko EJ. Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat. Diabetes Care. 2004;27(4):861-868.
36. Vermeulen A, Goemaere S, Kaufman JM. Testosterone, body composition and aging. J Endocrinol Invest. 1999;22(suppl 5):110-116.
37. World Health Organization. Diabetes mellitus. Report of a WHO study group. World Health Organ Tech Rep Ser. 1985;727:1-113.